76 results
Page 3 of 4
8-K
EX-99.1
1lbt4al435dqv6
31 Oct 12
Biocryst Provides Update Regarding BCX5191 Development Plan
12:00am
425
EX-99.1
s1c flvkjm5x0d9vfrqz
31 Oct 12
Business combination disclosure
12:00am
8-K
EX-99.1
9tecn8rvyq0g17
22 Oct 12
Entry into a Material Definitive Agreement
12:00am
425
EX-99.1
etdyd1u3f37m ebx7
22 Oct 12
Business combination disclosure
12:00am
8-K
EX-99.1
z8nbvl0p y0
18 Oct 12
Biocryst Pharmaceuticals and Presidio Pharmaceuticals to Merge
12:00am
425
EX-99.1
m81b 7hg6
18 Oct 12
Business combination disclosure
12:00am
8-K
EX-99.1
ipy3d
2 Aug 12
Biocryst Provides Corporate Update and Reports Second Quarter
12:00am
8-K
EX-99.1
xwq8128u8
24 Jul 12
Biocryst Announces Positive Results from Two Ulodesine Phase 2 Trials In Patients with Gout
12:00am
8-K
EX-99.1
8l3o 5t66b3xc
7 May 12
Biocryst Provides Corporate Update and Reports First Quarter
12:00am
8-K
EX-99.1
oyl qt26ipuu6kq7
16 Feb 12
Biocryst Reports Fourth Quarter and Full Year 2011 Financial Results
12:00am
8-K
EX-99.1
pu4m537zut0xzu d9
2 Nov 11
Biocryst Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2011 Financial Results
12:00am
8-K
EX-99.1
v6sneb03kp1vp44hp
6 Mar 07
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
37owwku4m8p
11 Jan 07
Jon P. Stonehouse Appointed Chief Executive Officer of Biocryst
12:00am
424B2
me0671b
16 Dec 05
Prospectus for primary offering
12:00am
424B2
k3zs1ayx zttz5
16 Dec 05
Prospectus for primary offering
12:00am